1. Home
  2. Companies
  3. AYA
  4. Announcements

Artrya (ASX:AYA)

ASX announcement history & article coverage

31
Total announcements
(in last 3 months)
5
With article
26
No article
Article coverage
16%
Transparent by design. Announcments by Artrya (ASX:AYA) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.

14 Oct 2026 · 05:23 pm AEST ASX Filing
Notice of Annual General Meeting/Proxy Form
Notice of Annual General MeetingProxy Form
6 Oct 2026 · 06:15 pm AEST ASX Filing
Application for quotation of securities - AYA
Appendix 2A
6 Oct 2026 · 06:12 pm AEST ASX Filing
Issue of Shares on Exercise of Securities & Cleansing Notice
Issued Capital - OtherCleansing Notice
2 Oct 2026 · 08:32 am AEST ⚡ Price SensitiveMaterialUnexpected ASX Filing
Huntsville Hospital Health System Commercial Agreement
Artrya signs five-year US agreement worth at least US$0.5 million with first SAPPHIRE participant
Web CastProgress Report
88
Artrya Converts First SAPPHIRE Participant Into Five-Year US Customer

30 Sept 2026 · 06:08 pm AEST ASX Filing
Ceasing to be a substantial holder
Ceasing to be a substantial holder
30 Sept 2026 · 05:05 pm AEST ASX Filing
Change in substantial holding
Change in substantial holding
29 Sept 2026 · 06:20 pm AEST ASX Filing
Becoming a substantial holder
Becoming a substantial holder
24 Sept 2026 · 08:19 am AEST ASX Filing
Becoming a substantial holder
Becoming a substantial holder
22 Sept 2026 · 05:03 pm AEST ASX Filing
Change in substantial holding
Change in substantial holding
18 Sept 2026 · 06:20 pm AEST ASX Filing
Ceasing to be a substantial holder from WAM/WAA/WMI/WAX
Ceasing to be a substantial holder
16 Sept 2026 · 04:57 pm AEST ASX Filing
Application for quotation of securities - AYA
Appendix 2A
16 Sept 2026 · 04:54 pm AEST ASX Filing
Issue of Shares on Exercise of Securities & Cleansing Notice
Issued Capital - OtherCleansing Notice
14 Sept 2026 · 04:53 pm AEST ASX Filing
Application for quotation of securities - AYA
Appendix 2A
14 Sept 2026 · 04:49 pm AEST ASX Filing
Issue of Shares on Exercise of Securities & Cleansing Notice
Issued Capital - OtherCleansing Notice
10 Sept 2026 · 05:25 pm AEST ASX Filing
Change in substantial holding
Change in substantial holding
8 Sept 2026 · 04:57 pm AEST ASX Filing
Application for quotation of securities - AYA
Appendix 2A
8 Sept 2026 · 04:56 pm AEST ASX Filing
Issue of Shares on Exercise of Securities & Cleansing Notice
Issued Capital - OtherCleansing Notice
1 Sept 2026 · 05:22 pm AEST ASX Filing
Application for quotation of securities - AYA
Appendix 2A
1 Sept 2026 · 05:18 pm AEST ASX Filing
Issue of Shares on Exercise of Securities & Cleansing Notice
Issued Capital - OtherCleansing Notice
1 Sept 2026 · 08:33 am AEST ⚡ Price SensitiveMaterial ASX Filing
FY26 Financial Results and Operational Update Presentation
Artrya reports FY26 results with commercial launch, $80M capital raise, and FDA clearance progress
Company PresentationPreliminary Final Report
85
Artrya Advances US Expansion with $80M Raise and FDA Clearance Momentum Healthcare Wrap - Week 36 (31 Aug -> 4 Sept) 2026 Wrap

27 Aug 2026 · 05:03 pm AEST ASX Filing
Application for quotation of securities - AYA
Appendix 2A
27 Aug 2026 · 04:57 pm AEST ASX Filing
Issue of Shares on Exercise of Securities &Cleansing Notice
Issued Capital - OtherCleansing Notice
25 Aug 2026 · 07:03 pm AEST ASX Filing
Application for quotation of securities - AYA
Appendix 2A
25 Aug 2026 · 07:03 pm AEST ASX Filing
Issue of Shares on Exercise of Securities & Cleansing Notice
Cleansing Notice
20 Aug 2026 · 07:59 am AEST ASX Filing
Appointment of Non-Executive Director - Helen Kurincic
Initial Director's Interest NoticeDirector Appointment/Resignation
19 Aug 2026 · 11:28 am AEST ASX Filing
Appendix 4G
Appendix 4G
19 Aug 2026 · 11:24 am AEST ASX Filing
Corporate Governance Statement
Corporate Governance
19 Aug 2026 · 11:16 am AEST ⚡ Price SensitiveMaterial ASX Filing
Appendix 4E and Annual Report to Shareholders
Artrya reports FY2026 loss of $25.18m, advances US commercial rollout with FDA clearances and $80m capital raise
Annual ReportTop 20 shareholders
85
Artrya Reports $25.18m FY26 Loss Amid US Commercial Launch and FDA Milestones Healthcare Wrap - Week 34 (17 Aug -> 21 Aug) 2026 Wrap
3 Aug 2026 · 12:34 pm AEST ASX Filing
Ceasing to be a substantial holder
Ceasing to be a substantial holder

29 July 2026 · 08:37 am AEST ⚡ Price SensitiveMaterial ASX Filing
June Quarterly Activities Report and Appendix 4C
Artrya advances U.S. commercial rollout and FDA submission with $74M cash position
Commitments Test Entity - Fourth Quarter Activity ReportCommitments Test Entity - Fourth Quarter Cashflow Report
85
Artrya Accelerates US Rollout with FDA Submission Imminent and $74M Cash Buffer Healthcare Wrap - Week 31 (27 July -> 31 July) 2026 Wrap
23 July 2026 · 08:30 am AEST ⚡ Price SensitiveMaterial ASX Filing
Northeast Georgia Health System goes live with Salix
Artrya's Salix® Platform Goes Live at Northeast Georgia Health System, Begins Revenue Generation
Progress Report
80
Artrya’s Salix Platform Goes Live at Northeast Georgia Health System, Begins Revenue Generation Healthcare Wrap - Week 30 (20 July -> 24 July) 2026 Wrap